Table 2.
Polymorphism | Patients (n = 312) | Controls (n = 479) | P (χ2) | Genetic models | OR; 95%CI | |
rs1800624 | TT | 248 | 343 | Additive | 0.64; 0.47-0.88 | |
AT | 62 | 123 | 0.012 | Dominant | 0.65; 0.46-0.91 | |
AA | 2 | 13 | Recessive | 0.23; 0.05-1.03 | ||
A | 10.6% | 15.6% | 0.005 | |||
rs1800625 | TT | 228 | 353 | Additive | 0.98; 0.73-1.33 | |
CT | 82 | 118 | 0.460 | Dominant | 1.03; 0.75-1.42 | |
CC | 2 | 8 | Recessive | 0.38; 0.08-1.80 | ||
C | 13.8% | 14.0% | 0.940 | |||
rs2070600 | GG | 174 | 303 | Additive | 1.29; 1.03-1.62 | |
AG | 112 | 148 | 0.086 | Dominant | 1.37; 1.02-1.83 | |
AA | 26 | 28 | Recessive | 1.46; 0.84-2.55 | ||
A | 26.3% | 21.3% | 0.022 |
OR: Odds ratio.